… sepsis, anticoagulation plays a key role in the treatment of COVID-19, however … for
COVID-19-coagulopathy (CIC Scoring) and stratification of patients for the purpose of …

… low-dose prophylactic anticoagulation is favoured over placebo or no anticoagulation in the
… with moderate and severe COVID-19, intermediate-dose anticoagulation may have little or …

… anticoagulants in COVID-19 patients. While randomized controlled trials are ideal, the rapid
spread and relatively high incidence of VTE events in COVID-19 … dose anticoagulation to be …

… of anticoagulation post-hospital discharge. For this phase of treatment, if required, an oral
anticoagulant is preferable to parenteral anticoagulant to … hospitalised with COVID-19, reported …

… of coronavirus disease 2019 (COVID-19). This systematic review synthesizes current data on
thrombosis risk, prognostic implications, and anticoagulation effects in COVID-19… COVID-19 …

… anticoagulation in this vulnerable patient population should be considered carefully and
addressed appropriately. Our recommendation supports the use of anticoagulation in COVID-19 …

… complications of coronavirus disease-2019 (COVID-19), … rates than similarly critically ill
non-COVID cohorts [Citation1]. … regarding optimal anticoagulation (AC) strategies in COVID-19. In …

… anticoagulation in COVID-19 has been debated and data remain anecdotal. Hypothesis:
We hypothesize that therapeutic anticoagulation is … anticoagulation in hospitalized COVID-19 …

… in COVID-19 … of anticoagulants in COVID-19 remains an area of conjecture with no definite
guidelines published to date highlighting the timing, dosage and duration of anticoagulation …

… COVID-19 patients ensues. We aim at reviewing the literature for anticoagulation in the setting
of COVID-19 infection to provide a summary on anticoagulation for this patient population. …